Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now presents a consolidated 'Locations' section with listed sites (Arizona, Florida, Georgia, Minnesota, New York, Pennsylvania, Tennessee, Texas, Washington, Alberta, Ontario) and removes the prior per-state headers (e.g., 'Arizona Locations'). The revision has been updated to v3.3.3.SummaryDifference1%

- Check8 days agoChange DetectedThe new screenshot shows a layout refresh while preserving all core study details (title, brief summary, eligibility criteria, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoChange DetectedThe updates appear to be cosmetic adjustments to the page layout (header alignment, spacing, and navigation) with no changes to core study content, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoChange DetectedNo additions or deletions to core study content detected; observed differences appear to be minor visual/layout changes in the page rendering.SummaryDifference0.1%

- Check29 days agoChange DetectedPublication section text updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision version updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedThe government funding lapse notice banner on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.